Personal information

Emails & domains

Verified email domains

Websites & social links

Lab Website

Other IDs

Scopus Author ID: 22937130700

Countries

Italy, Spain, United States

Activities

Collapse all

Employment (2)

University of Turin: Turin, IT

2021-12-27 to present | Associate Professor
Employment
Source: Self-asserted source
Chiara Ambrogio

University of Turin: Turin, Piemonte, IT

2019-12-23 to 2021-12-27 | Assistant Professor (Department of Molecular Biotechnology and Health Science)
Employment
Source: Self-asserted source
Chiara Ambrogio

Education and qualifications (3)

Harvard Medical School: Boston, MA, US

2016-04-04 to 2019-12-23 | Research Associate (DFCI Medical Oncology)
Education
Source: Self-asserted source
Chiara Ambrogio

Centro Nacional de Investigaciones Oncológicas: Madrid, Madrid, ES

2009 to 2016 | PostDoc (Molecular Oncology)
Education
Source: Self-asserted source
Chiara Ambrogio

University of Torino: Torino, IT

2004 to 2008 | PhD
Education
Source: Self-asserted source
Chiara Ambrogio

Funding (2)

From the understanding of KRAS-RAF membrane dynamics to new therapeutic strategies in cancer

2021-08-01 to 2026-07-31 | Grant
European Research Council (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.9613081
GRANT_NUMBER: 101001288
Source: Self-asserted source
Chiara Ambrogio via DimensionsWizard

Functional and Therapeutic role for RAS dimerization

2018-12-01 to 2020-11-30 | Grant
Lung Cancer Research Foundation (New York, US)
URL: https://app.dimensions.ai/details/grant/grant.100069564
GRANT_NUMBER:

2018-Ambrogio
Source: Self-asserted source
Chiara Ambrogio via DimensionsWizard

Works (50 of 85)

Items per page:
Page 1 of 2

ALK in cancer: from function to therapeutic targeting

Nature Reviews Cancer
2025-03-07 | Journal article
DOI: 10.1038/s41568-025-00797-9
Contributors: Claudia Voena; Chiara Ambrogio; Fabio Iannelli; Roberto Chiarle
Source: check_circle
Crossref

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment

Nature Communications
2025-01-02 | Journal article
DOI: 10.1038/s41467-024-55378-5
Contributors: Bassel Alsaed; Linh Lin; Jieun Son; Jiaqi Li; Johannes Smolander; Timothy Lopez; Pinar Ö. Eser; Atsuko Ogino; Chiara Ambrogio; Yoonji Eum et al.
Source: check_circle
Crossref

Experimental variables determine the outcome of RAS-RAS interactions

Journal of Biological Chemistry
2024-11 | Journal article
DOI: 10.1016/j.jbc.2024.107859
Contributors: Zhiwei Zhou; Tra Ly Nguyen; Xingxiao Li; Christel Poujol; Ewa Berlinska; Sandra Vietti Michelina; Jonas N. Kapp; Andreas Plückthun; Monte M. Winslow; Chiara Ambrogio et al.
Source: check_circle
Crossref

Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node

Molecular Oncology
2024-06 | Journal article
DOI: 10.1002/1878-0261.13605
Contributors: Rossella Scardaci; Ewa Berlinska; Pietro Scaparone; Sandra Vietti Michelina; Edoardo Garbo; Silvia Novello; David Santamaria; Chiara Ambrogio
Source: check_circle
Crossref

Cancer Hallmarks: Piecing the Puzzle Together

Cancer Discovery
2024-04-04 | Journal article
DOI: 10.1158/2159-8290.CD-24-0097
Contributors: Maria P. Alcolea; Direna Alonso-Curbelo; Chiara Ambrogio; Susan Bullman; Ana Luísa Correia; Aurélie Ernst; Christopher J. Halbrook; Gemma L. Kelly; Amanda W. Lund; Daniela F. Quail et al.
Source: check_circle
Crossref

Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2022.1085672
EID:

2-s2.0-85146950961

Part of ISSN: 2234943X
Contributors: Mura, G.; Karaca Atabay, E.; Menotti, M.; Martinengo, C.; Ambrogio, C.; Giacomello, G.; Arigoni, M.; Olivero, M.; Calogero, R.A.; Chiarle, R. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

The Anti–Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers

Journal of Thoracic Oncology
2023 | Journal article
DOI: 10.1016/j.jtho.2022.11.001
EID:

2-s2.0-85144434307

Part of ISSN: 15561380 15560864
Contributors: Ferrara, R.; Ricciuti, B.; Ambrogio, C.; Trapani, D.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Exploiting signaling rewiring in cancer cells with co‐existing oncogenic drivers

Molecular Oncology
2023-11 | Journal article
DOI: 10.1002/1878-0261.13547
Contributors: Roberto Chiarle; Chiara Ambrogio
Source: check_circle
Crossref

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma

Science Translational Medicine
2023-06-28 | Journal article
DOI: 10.1126/scitranslmed.abo3826
Contributors: Cristina Mastini; Marco Campisi; Enrico Patrucco; Giulia Mura; Antonio Ferreira; Carlotta Costa; Chiara Ambrogio; Giulia Germena; Cinzia Martinengo; Silvia Peola et al.
Source: check_circle
Crossref

YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors

Nature Cancer
2023-06-27 | Journal article
DOI: 10.1038/s43018-023-00580-5
Contributors: Alessia Mira; Chiara Ambrogio
Source: check_circle
Crossref

Data from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527247
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

Data from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527247.v1
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

Data from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6529215
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

Data from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6529215.v1
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

Supplementary Fig S1-S5 from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22469394
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

Supplementary Fig S1-S5 from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22469394.v1
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

Supplementary Figure from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22475919
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

Supplementary Figure from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22475919.v1
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

supplementary Table 1 from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22469391
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

supplementary Table 1 from Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22469391.v1
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref

Supplementary Table 1 from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22475916
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

Supplementary Table 1 from Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22475916.v1
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref

Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer

Clinical Cancer Research
2022 | Journal article
DOI: 10.1158/1078-0432.CCR-21-2719
EID:

2-s2.0-85128270227

Part of ISSN: 15573265 10780432
Contributors: Ricciuti, B.; Son, J.; Okoro, J.J.; Mira, A.; Patrucco, E.; Eum, Y.; Wang, X.; Paranal, R.; Wang, H.; Lin, M. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comparative genomic profiling identifies targetable brain metastasis drivers in non-small cell lung cancer

ResearchSquare
2022 | Other
DOI: 10.21203/rs.3.rs-1320380
EID:

2-s2.0-85134101032
Contributors: Nicos, M.; Harbers, L.; Patrucco, E.; Kramer-Drauberg, M.; Zhang, X.; Voena, C.; Kowalczyk, A.; Bozyk, A.; Peksa, R.; Jarosz, B. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer

Annals of Oncology
2022 | Journal article
DOI: 10.1016/j.annonc.2022.07.005
EID:

2-s2.0-85136309871

Part of ISSN: 15698041 09237534
Contributors: Ricciuti, B.; Alessi, J.V.; Elkrief, A.; Wang, X.; Cortellini, A.; Li, Y.Y.; Vaz, V.R.; Gupta, H.; Pecci, F.; Barrichello, A. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis

Gastroenterology
2022 | Journal article
DOI: 10.1053/j.gastro.2021.12.242
EID:

2-s2.0-85126301597

Part of ISSN: 15280012 00165085
Contributors: Costamagna, A.; Natalini, D.; Camacho Leal, M.D.P.; Simoni, M.; Gozzelino, L.; Cappello, P.; Novelli, F.; Ambrogio, C.; Defilippi, P.; Turco, E. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

JTO Clinical and Research Reports
2022 | Journal article
DOI: 10.1016/j.jtocrr.2022.100435
EID:

2-s2.0-85143792561

Part of ISSN: 26663643
Contributors: Nicoś, M.; Harbers, L.; Patrucco, E.; Kramer-Drauberg, M.; Zhang, X.; Voena, C.; Kowalczyk, A.; Bożyk, A.; Pęksa, R.; Jarosz, B. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)

Cancer Treatment Reviews
2022 | Journal article
DOI: 10.1016/j.ctrv.2021.102335
EID:

2-s2.0-85122627418

Part of ISSN: 15321967 03057372
Contributors: Tabbò, F.; Pisano, C.; Mazieres, J.; Mezquita, L.; Nadal, E.; Planchard, D.; Pradines, A.; Santamaria, D.; Swalduz, A.; Ambrogio, C. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V

European Journal of Cancer
2022 | Journal article
DOI: 10.1016/S0959-8049(22)00851-6
EID:

2-s2.0-85140429478

Part of ISSN: 18790852 09598049
Contributors: Coma, S.; Musteanu, M.; Mira, A.; Caffarra, C.; Morrison, D.; Ambrogio, C.; Barbacid, M.; Pachter, J.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma

Blood
2022-02-03 | Journal article
DOI: 10.1182/blood.2020008136
Contributors: Elif Karaca Atabay; Carmen Mecca; Qi Wang; Chiara Ambrogio; Ines Mota; Nina Prokoph; Giulia Mura; Cinzia Martinengo; Enrico Patrucco; Giulia Leonardi et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Discoveries in the redox regulation of KRAS

International Journal of Biochemistry and Cell Biology
2021 | Journal article
DOI: 10.1016/j.biocel.2020.105901
EID:

2-s2.0-85098172346

Part of ISSN: 18785875 13572725
Contributors: Kramer-Drauberg, M.; Ambrogio, C.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer

Trends in Cancer
2021 | Journal article
DOI: 10.1016/j.trecan.2020.11.005
EID:

2-s2.0-85097474076

Part of ISSN: 24058033
Contributors: Nokin, M.-J.; Ambrogio, C.; Nadal, E.; Santamaria, D.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

A structural model of a Ras–Raf signalosome

Nature Structural & Molecular Biology
2021-10 | Journal article
DOI: 10.1038/s41594-021-00667-6
Contributors: Venkatesh P. Mysore; Zhi-Wei Zhou; Chiara Ambrogio; Lianbo Li; Jonas N. Kapp; Chunya Lu; Qi Wang; Maxwell R. Tucker; Jeffrey J. Okoro; Gabriela Nagy-Davidescu et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

ERK Inhibitor LY3214996-Based Treatment Strategies for RAS-Driven Lung Cancer

Molecular Cancer Therapeutics
2021-04-01 | Journal article
DOI: 10.1158/1535-7163.MCT-20-0531
Contributors: Jens Köhler; Yutong Zhao; Jiaqi Li; Prafulla C. Gokhale; Hong L. Tiv; Aine R. Knott; Margaret K. Wilkens; Kara M. Soroko; Mika Lin; Chiara Ambrogio et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A LIBRETTO to orchestrate targeted therapy

Nature Cancer
2020 | Journal article
DOI: 10.1038/s43018-020-00144-x
EID:

2-s2.0-85096108231

Part of ISSN: 26621347
Contributors: Marmarelis, M.E.; Chiarle, R.; Ambrogio, C.; Aggarwal, C.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

A structural model of a Ras-Raf signalosome

bioRxiv
2020 | Other
DOI: 10.1101/2020.07.15.165266
EID:

2-s2.0-85098897155

Part of ISSN: 26928205
Contributors: Mysore, V.P.; Zhou, Z.-W.; Ambrogio, C.; Li, L.; Kapp, J.N.; Lu, C.; Wang, Q.; Tucker, M.R.; Okoro, J.J.; Nagy-Davidescu, G. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma

JCI Insight
2020 | Journal article
DOI: 10.1172/jci.insight.137869
EID:

2-s2.0-85089170655

Part of ISSN: 23793708
Contributors: Nokin, M.-J.; Darbo, E.; Travert, C.; Drogat, B.; Lacouture, A.; José, S.S.; Cabrera, N.; Turcq, B.; Prouzet-Mauleon, V.; Falcone, M. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

KRASQ61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer

Cancer Research
2020-09-01 | Journal article
DOI: 10.1158/0008-5472.CAN-20-0448
Contributors: Zhi-Wei Zhou; Chiara Ambrogio; Asim K. Bera; Qing Li; Xing-Xiao Li; Lianbo Li; Jieun Son; Sudershan Gondi; Jiaqi Li; Emily Campbell et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer

eBioMedicine
2019-11 | Journal article
DOI: 10.1016/j.ebiom.2019.10.012
Contributors: Haiyun Wang; Qi Lv; Yue Xu; Zhaoqing Cai; Jie Zheng; Xiaojie Cheng; Yao Dai; Pasi A. Jänne; Chiara Ambrogio; Jens Köhler
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Nature Medicine
2019-01 | Journal article
DOI: 10.1038/s41591-018-0262-9
Contributors: Matteo Menotti; Chiara Ambrogio; Taek-Chin Cheong; Chiara Pighi; Ines Mota; Seth H. Cassel; Mara Compagno; Qi Wang; Riccardo Dall’Olio; Valerio G. Minero et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer

Clinical Cancer Research
2019-01-01 | Journal article
DOI: 10.1158/1078-0432.CCR-18-2062
Contributors: Ibiayi Dagogo-Jack; Pablo Martinez; Beow Y. Yeap; Chiara Ambrogio; Lorin A. Ferris; Christine Lydon; Tom Nguyen; Nicholas A. Jessop; A. John Iafrate; Bruce E. Johnson et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib

Journal of Thoracic Oncology
2018 | Journal article
DOI: 10.1016/j.jtho.2018.03.026
EID:

2-s2.0-85046421862

Part of ISSN: 15561380 15560864
Contributors: Abravanel, D.L.; Nishino, M.; Sholl, L.M.; Ambrogio, C.; Awad, M.M.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Back to the bench? MEK and ERK inhibitors for the treatment of KRAS mutant lung adenocarcinoma

Current Medicinal Chemistry
2018 | Journal article
DOI: 10.2174/0929867324666170530093100
EID:

2-s2.0-85043304430

Part of ISSN: 1875533X 09298673
Contributors: Köhler, J.; Catalano, M.; Ambrogio, C.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Ground-glass nodules of the lung in never-smokers and smokers: Clinical and genetic insights

Translational Lung Cancer Research
2018 | Journal article
DOI: 10.21037/tlcr.2018.07.04
EID:

2-s2.0-85052294684

Part of ISSN: 22264477 22186751
Contributors: Kobayashi, Y.; Ambrogio, C.; Mitsudomi, T.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Cell
2018 | Journal article
DOI: 10.1016/j.cell.2017.12.020
EID:

2-s2.0-85040453657

Part of ISSN: 10974172 00928674
Contributors: Ambrogio, C.; Köhler, J.; Zhou, Z.-W.; Wang, H.; Paranal, R.; Li, J.; Capelletti, M.; Caffarra, C.; Li, S.; Lv, Q. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

Clinical Cancer Research
2018-10-01 | Journal article
DOI: 10.1158/1078-0432.CCR-17-3438
Contributors: Shuai Li; Shengwu Liu; Jiehui Deng; Esra A. Akbay; Josephine Hai; Chiara Ambrogio; Long Zhang; Fangyu Zhou; Russell W. Jenkins; Dennis O. Adeegbe et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance

Cell Adhesion & Migration
2018-04-03 | Journal article
DOI: 10.1080/19336918.2018.1445954
Contributors: Chiara Ambrogio; Elodie Darbo; Sam W. Lee; David Santamaría
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A Braf kinase-inactive mutant induces lung adenocarcinoma

Nature
2017 | Journal article
DOI: 10.1038/nature23297
EID:

2-s2.0-85027336032

Part of ISSN: 14764687 00280836
Contributors: Nieto, P.; Ambrogio, C.; Esteban-Burgos, L.; Gómez-López, G.; Blasco, M.T.; Yao, Z.; Marais, R.; Rosen, N.; Chiarle, R.; Pisano, D.G. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma

Oncogene
2017 | Journal article
DOI: 10.1038/onc.2016.385
EID:

2-s2.0-84992413593

Part of ISSN: 14765594 09509232
Contributors: Ambrogio, C.; Barbacid, M.; Santamaría, D.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎

Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells

Nature
2017 | Journal article
DOI: 10.1038/nature21406
EID:

2-s2.0-85016152789

Part of ISSN: 14764687 00280836
Contributors: Compagno, M.; Wang, Q.; Pighi, C.; Cheong, T.-C.; Meng, F.-L.; Poggio, T.; Yeap, L.-S.; Karaca, E.; Blasco, R.B.; Langellotto, F. et al.
Source: Self-asserted source
Chiara Ambrogio via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (12 reviews for 6 publications/grants)

Review activity for Cancer cell. (1)
Review activity for Cell reports medicine. (1)
Review activity for iScience. (2)
Review activity for Nature cancer. (4)
Review activity for Nature communications (2)
Review activity for Oncogene. (2)
How many people are using ORCID?